↓ Skip to main content

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme

Overview of attention for article published in Cardiovascular Diabetology, January 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
1 tweeter
patent
1 patent

Citations

dimensions_citation
180 Dimensions

Readers on

mendeley
119 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme
Published in
Cardiovascular Diabetology, January 2012
DOI 10.1186/1475-2840-11-3
Pubmed ID
Authors

Odd Johansen, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Patel, Hans-Juergen Woerle

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Russia 1 <1%
Mexico 1 <1%
United Kingdom 1 <1%
South Africa 1 <1%
Brazil 1 <1%
United States 1 <1%
Netherlands 1 <1%
Canada 1 <1%
Other 0 0%
Unknown 110 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 35 29%
Student > Master 22 18%
Student > Postgraduate 11 9%
Student > Ph. D. Student 8 7%
Unspecified 7 6%
Other 36 30%
Readers by discipline Count As %
Medicine and Dentistry 76 64%
Unspecified 12 10%
Agricultural and Biological Sciences 7 6%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Social Sciences 5 4%
Other 12 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 November 2016.
All research outputs
#3,387,527
of 12,483,518 outputs
Outputs from Cardiovascular Diabetology
#163
of 737 outputs
Outputs of similar age
#91,871
of 281,182 outputs
Outputs of similar age from Cardiovascular Diabetology
#31
of 109 outputs
Altmetric has tracked 12,483,518 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 737 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 281,182 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.